Identification of genes involved in imatinib resistance in CML: a gene-expression profiling approach
about
Tenascin-C promotes melanoma progression by maintaining the ABCB5-positive side populationGene expression profiling reveals different pathways related to Abl and other genes that cooperate with c-Myc in a model of plasma cell neoplasia.Synergy between proteasome inhibitors and imatinib mesylate in chronic myeloid leukemia.Predictors of primary imatinib resistance in chronic myelogenous leukemia are distinct from those in secondary imatinib resistance.A gene expression signature of CD34+ cells to predict major cytogenetic response in chronic-phase chronic myeloid leukemia patients treated with imatinib.DNA microarrays in herbal drug researchEnhancing SHP-1 expression with 5-azacytidine may inhibit STAT3 activation and confer sensitivity in lestaurtinib (CEP-701)-resistant FLT3-ITD positive acute myeloid leukemia.Role of BCR/ABL gene-expression levels in determining the phenotype and imatinib sensitivity of transformed human hematopoietic cellsGene expression profile of circulating CD34(+) cells and granulocytes in chronic myeloid leukemiaKnock-down of Kaiso induces proliferation and blocks granulocytic differentiation in blast crisis of chronic myeloid leukemiaPossible role for gene expression profiling in predicting responses to conventional or targeted drugs in patients with chronic myeloid leukemia.Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet.A novel isoform of the B cell tyrosine kinase BTK protects breast cancer cells from apoptosis.ArgBP2 and the SoHo family of adapter proteins in oncogenic diseasesTherapy of chronic myeloid leukemia: twilight of the imatinib era?Role of gene-expression profiling in chronic myeloid leukemia.Mechanisms of resistance to BCR-ABL kinase inhibitors.Prognostic Significance of Treatment Response in CML in View of Current Recommendations for Treatment and Monitoring.Downregulation of miR-451 in Tunisian chronic myeloid leukemia patients: potential implication in imatinib resistance.OCT-1 function varies with cell lineage but is not influenced by BCR-ABL.Gene expression profiling of chronic myeloid leukemia with variant t(9;22) reveals a different signature from cases with classic translocation.Imatinib-resistant chronic myeloid leukemia (CML): Current concepts on pathogenesis and new emerging pharmacologic approaches.Bruton's tyrosine kinase is not essential for Bcr-Abl-mediated transformation of lymphoid or myeloid cells.Protein-coding genes and long noncoding RNAs are differentially expressed in dasatinib-treated chronic myeloid leukemia patients with resistance to imatinib.PTPRG and PTPRC modulate nilotinib response in chronic myeloid leukemia cells.PTCH1 expression at diagnosis predicts imatinib failure in chronic myeloid leukaemia patients in chronic phase.Differential proteomic profile of leukemic CD34+ progenitor cells from chronic myeloid leukemia patients.
P2860
Q24634572-FC3B8D0E-C271-4F2E-B10A-3BC6FDCB87EFQ30444311-33F5DF50-9D9D-4438-84EF-5C24AA0E2E40Q33482818-27F2C42C-07D3-40DC-BE82-09589315A0DDQ33561227-79FA39E1-4B85-4AC4-8D12-1918534BCA5CQ33597519-D3067C31-D0CF-42CB-A6ED-D03236B8E799Q35219881-2EC93E5D-1E63-4807-9DD6-01274DD448CBQ35835233-C49AEDE7-2F5D-4CBF-A752-B820D86C0733Q35839918-8A50932B-C5DE-4EE1-95F0-DCC3444E7975Q36168167-DFA1F6E2-8A20-49AC-955F-B7EEA23477BCQ36288848-0B14B52F-7B97-4D23-B498-2ACC6E4D0137Q37132871-DB084B5A-3F34-449C-98A7-3B166D80A478Q37163550-9ABC38F8-E9F4-42C8-B231-996A05EB8BD7Q37222219-580A35EC-B866-4BD3-B74C-B2A7F98D9123Q37406767-3D1A0D3B-E872-4EC4-B835-9041D3CD2EFCQ37593435-03FE3706-7A85-4088-9975-1E7C9196498CQ37810111-C10D5FEE-9FCF-46E8-828B-EB3ED2894B23Q37836923-2FFCBF02-998D-40A4-9943-4962D606606FQ38095956-869BB284-CF31-4DA7-B326-20550C271444Q39477519-B7174A7E-DCF0-43E1-9441-34481E2BE1BFQ39640517-1027D47C-9AD8-46F0-A40D-31328065A8A8Q40856474-AF4A328A-CC8B-4D2F-AF6C-E4F56DA88A63Q43078241-7AC564E6-3035-40F6-8FFE-3840ACF83D3AQ45752089-DA2F794F-4CAA-48B0-9DD5-5625E314A2E6Q46970334-CA8DB214-E8A8-4E45-AB35-59F0D0539014Q52430614-0B2FF75C-401C-456A-83D0-2F8EDA4489A1Q53017093-E53A7618-0BAA-4357-8B5B-257F03472032Q54978822-05F34CD1-DFEC-4979-9E20-82792E806D67
P2860
Identification of genes involved in imatinib resistance in CML: a gene-expression profiling approach
description
article
@en
im Juni 2006 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2006
@uk
name
Identification of genes involv ...... -expression profiling approach
@en
Identification of genes involv ...... -expression profiling approach
@nl
type
label
Identification of genes involv ...... -expression profiling approach
@en
Identification of genes involv ...... -expression profiling approach
@nl
prefLabel
Identification of genes involv ...... -expression profiling approach
@en
Identification of genes involv ...... -expression profiling approach
@nl
P2093
P2860
P356
P1433
P1476
Identification of genes involv ...... -expression profiling approach
@en
P2093
Fernández-Ruiz E
Lombardía L
Martínez J
Martínez P
Odriozola J
Steegmann JL
Villalón L
P2860
P2888
P304
P356
10.1038/SJ.LEU.2404197
P577
2006-06-01T00:00:00Z